Medical Director, Clinical Development, Oncology

Role: Serve as a key clinical contributor in Lyell's development of next-generation CAR T-cell therapies for solid tumors and hematologic malignancies, providing medical and scientific leadership across clinical trials. Responsibilities: lead trial design, oversee trial execution, analyze data, support regulatory submissions (IND, BLA), and contribute to safety monitoring and compliance with GCP standards. Collaborate with cross-functional teams including Clinical Operations, Biostatistics, Regulatory, and Medical Affairs; represent Lyell at external scientific and regulatory engagements. Requirements: MD with at least 5 years of oncology clinical research experience, ideally in cell therapy or immuno-oncology; industry experience in biotech/pharma; familiarity with regulatory processes and clinical trial oversight; strong scientific communication skills. Preferred: Board certification in oncology or hematology, advanced degrees (PhD), previous experience with regulatory interactions and early-stage clinical development. High-Value: focus on innovative cell therapy modalities, clinical trials in oncology, regulatory engagement, and early to mid-phase development (IND to Ph1-3). Work setup: not specified, salary range $240K-$300K plus bonus, with participation in equity plan.